FOR PROFESSIONAL INVESTORS ONLY

Lever VC

Sector-specialist fund focused entirely on alternative protein
Principal Partners have proven track record investing in over 60 alternative protein deals, with stellar returns and exits
Global coverage of sector with exceptional deal flow and on-the- ground presence in the U.S., U.K., France, Israel, India, Hong Kong, mainland China, and Singapore

LEVER VC: PROVEN SECTOR EXPERTS INVESTING IN THE FUTURE OF PROTEIN

152%

Gross IRR

2.5x

Multiple on Invested Capital

50 Million

Target Fund Size

Fund Type

Growth

Geographies

International

Industry Focus

Alternative Proteins

Fund Lifetime
7+1+1 years

Status of Fundraising

42 Million Closed

Closing Date

June 2021

Track Records

As part of Venture Smart’s rigorous selection and due diligence process, we analyse the fund’s investment record for the specific fund strategy in great detail. We scrutinize investment level performance, comparing investment strategy with results and understanding the team’s actions to drive overperformance and manage under performance.

For definitions of investment terms and metrics please review our glossary.

Why Lever VC

Venture Smart, including its management and advisors, only offers investments that have gone through a rigorous due diligence process once we are convinced of the merits of the investment opportunity. 

For definitions of investment terms and metrics please review our glossary.

Global need for alternative proteins

Owing to supply constraints in the animal proteins industry, alternative proteins will make up one-third of the global protein market by mid-century, with sales of plant-based meat alone reaching an estimated US$140 billion by 2029.

Secular shift in consumer preferences

Consumer considerations of health, sustainability and animal welfare are driving the shift toward alternative proteins. Interest is particularly strong among Gen-Z and millennial consumers, who are set to have the highest spending power over the next decade.

Increasing pace of investment and acquisition

Leading investment firms and major food companies have invested more than US$4 billion in alternative protein startups in the past five years. The pace of acquisitions is also continually increasing, providing ample opportunity for liquidity events.

Unparalleled track record

Investment team has collectively made 60+ alternative protein investments; partners Nick Cooney and Lawrence Chu have a track record of 8.6x TVPI and 86% IRR, and 6.5x TVPI and 69% IRR, respectively.

Proven performance; limited blind pool risk

Since initial deployment in July 2019, the fund has made 14 investments and achieved a Multiple on Invested Capital of 2.5x and an IRR of 152%. A third closing at ~US$47 million will be completed in March 2021.

Terms & Legal

Lever VC

Fund Manager

Venture Smart Financial Group

Investment Manager

Lever VC

Carry and Management Fee

20% / 2.5%

Setup fee(one-time) for GP

Not Applicable

Tax status

TBC

Other Charges

Not Applicable

Remarks

US$250,000 minimum investment amount

留下您的聯絡方式以了解更多

  •  
免責聲明

警告聲明

過往表現並不代表未來表現。由於貨幣波動,回報可能會增加或減少。所有業績數據均按資產淨值計算,並扣除費用及再投資的股利,並且不考慮發行和贖回單位時產生的佣金和成本。以美元/港元為基礎的投資者在投資以美元/港元以外的貨幣計價的產品時,將面臨貨幣波動的風險。

如果某股份類別的成立時間少於12個日曆月,則無法提供表現數據。但是,如果該股票類別的成立時間超過12個日曆月,則會在基金資訊文件中提供同一基金的其他股票類別的表現數據。由於對沖策略和費用等因素,股票類別之間的表現可能有所不同。

重要信息

  • 該投資涉及可能導致部分或全部投資損失的風險。
  • 投資者不應僅依靠本文件做出任何投資決定。您應閱讀並理解發行文件,以了解包括風險因素在內的更多基金細節。
logo_only

意博金融致力為客戶提供個人化資產管理方案,把握環球投資機遇。

聯絡我們

總部及主要營業地點

香港銅鑼灣希慎道18號利園五期23樓

銅鑼灣辦公室

香港銅鑼灣新寧道8號中國太平大廈二期12樓